Pexelizumab structure
|
Common Name | Pexelizumab | ||
|---|---|---|---|---|
| CAS Number | 219685-93-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PexelizumabPexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction[1][2]. |
| Name | h5G1.1-scFv |
|---|
| Description | Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Pexelizumab (h5G1. 1-SC) 抑制 5G1.1 单抗的结合,IC50 为 1.5 nM[2]。 |
| References |
| No Any Chemical & Physical Properties |